TDR Details the DEA Compliance Layer Emerging From Medical Cannabis Rescheduling

The Dales Report explained that state-licensed medical cannabis operators seeking federal Schedule III protections may face DEA registration, ownership disclosure and new personnel compliance requirements. Oklahoma medical businesses should prepare for a dual state and federal oversight model that could deliver 280E relief while increasing documentation, background and facility-control costs.